How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Xembify cost savings if eligible
The Xembify patient assistance program can provide your medication for free. We simply charge $49 per month for each medication to cover the cost of our services. With NiceRx, you will only pay $49 to obtain your Xembify, regardless of the retail price.
Am I eligible for the Xembify patient assistance program?
To find out if you are eligible for Xembify assistance you can apply online using our enrollment application. Each pharmaceutical company sets its eligibility criteria, and we will review your application individually to determine if you may be eligible. The three main factors to consider are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Xembify patient assistance program?
Our application process aims to make it as easy as possible to apply for the Xembify patient assistance program. The first step is to complete our online enrollment application. We will ask you for details about your healthcare provider, your insurance plan, and your household income as this information is required by the pharmaceutical companies. We may be able to help you apply for other patient assistance programs too, so be sure to tell us about any medications you are taking as well as Xembify.
NiceRx will review your application and determine whether you may be eligible for Xembify assistance. If so, we will handle the full enrollment process for you and prepare all required documents for your healthcare provider to sign. Once you are successfully enrolled in the Xembify patient assistance program, we will help you manage your prescription refills by requesting refills on your behalf throughout your enrollment period. At the end of your enrollment period, we will contact you for updated information and seek to re-enroll you so you can continue to access affordable Xembify.
Is NiceRx a Xembify coupons provider?
NiceRx is a service provider that helps eligible individuals access the Xembify patient assistance program. We do not offer trial offers or free Xembify samples. When obtaining your medication through NiceRx, you will only pay $49 a month per medication. This will likely save you more money than if you were to use Xembify coupons, discount cards, or Xembify copay cards.
Can NiceRx help me get Xembify if I have insurance?
NiceRx may be able to help you if your insurance company will not pay for your Xembify medication. We may also be able to help if you have a high copay or coinsurance responsibility. Whether you have insurance or not, apply online using our enrollment application to find out more.
How much does Xembify cost without insurance?
Xembify prices without insurance will vary depending on how much you buy. Prices will also vary by retailer. As a guide, Xembify subcutaneous solution klhw 20% typically costs $190 for a supply of 5 milliliters.
How much does Xembify cost with insurance?
The copay for Xembify will vary by the terms of your healthcare plan. To find out what you might need to pay for Xembify with insurance, your insurance provider or pharmacist will be able to help you calculate the copay costs with your current insurance.
What is Xembify?
Xembify (immune globulin subcutaneous, human- klhw) is a 20% immune globulin solution for subcutaneous injection, manufactured by Grifols Therapeutics LLC. It has FDA approval (U.S. Food and Drug Administration) for the treatment of primary humoral immunodeficiency (PI) in patients 2 years of age and older.
Warning – Thrombosis. See the full prescribing information for a complete boxed warning. Thrombosis may occur with immune globulin products, including Xembify. Risk factors are advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis can occur without known risk factors.
For patients at risk of thrombosis, administer Xembify at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.
What doses of Xembify are available?
Xembify is available in solution form, in the following doses: 0.2 g/ mL (200 mg/mL; 20%) protein solution for subcutaneous infusion.
Xembify is for subcutaneous administration only. Before switching to Xembify, obtain the patient’s serum IgG trough level to guide dose adjustment. When switching from immune globulin intravenous (human), 10% (IVIG) to Xembify, calculate the dose by using a dose adjustment factor.
Start Xembify treatment one week after the last IVIG infusion. Calculate an initial weekly dose by converting the monthly (or every 3 weeks) IVIG dose into an equivalent weekly dose and increasing it using a dose adjustment factor. When administering use up to 6 infusion sites at the same time, at least 2 inches between sites, avoiding any bony areas. Rotate sites for each administration.
Always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Xembify active ingredients
The active ingredient in Xembify is immune globulin, subcutaneous human.
Xembify side effects
The most common side effects of Xembify in clinical trials include:
- Infusion site erythema (redness), pain, swelling, bruising, nodule, pruritus (itching), induration (firmness), scab, edema
In rare instances, Xembify can cause more serious adverse reactions. These can include:
- Hypersensitivity and anaphylactic reactions. IgA deficient patients with antibodies against IgA are at increased risk of developing severe hypersensitivity or anaphylactic reactions
- Aseptic Meningitis Syndrome (AMS)
- Monitor renal function in patients at risk for renal failure
- Hemolysis – risk factors include high doses and non-O blood group
- Pulmonary adverse reactions (transfusion-related acute lung injury [TRALI])
- Xembify is made from human plasma – risk of transmitting infectious agents, e.g., viruses such as Creutzfeldt-Jakob disease (CJD)
Your doctor will assess the benefits of using Xembify against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Xembify to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Xembify drug interactions
Xembify can interact with other medications. These include:
- The passive transfer of antibodies may interfere with the response to live virus vaccines, such as measles, mumps, rubella, and varicella
This list is not exhaustive and other prescription drugs may interact with Xembify.
You should not use Xembify if you:
- Are allergic to the active ingredient immune globulin subcutaneous human
- Have had an anaphylactic or severe systemic reaction to human immunoglobulin or other inactive ingredients of Xembify such as polysorbate 80
- Are IgA deficient with antibodies against IgA and have a history of hypersensitivity
Talk to your doctor before using Xembify if you:
- Are taking any of the medications that could interact with Xembify
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
- Are over 65 years
- Have heart problems, or blood circulation problems
- Have had a stroke or blood clot
- Have kidney disease
- Have diabetes
- Have sepsis (an infection)
- Use estrogens (birth control pills or hormone replacement therapy)
- Have been on long-term bed rest
- Have a central intravenous (IV) catheter in place
Xembify is the trademark brand name for immune globulin subcutaneous human manufactured by Grifols Therapeutics LLC. A generic version of immune globulin subcutaneous human is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Xembify savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.